Matches in Wikidata for { <http://www.wikidata.org/entity/Q92240934> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q92240934 description "article scientifique publié en 2019" @default.
- Q92240934 description "artículu científicu espublizáu en marzu de 2019" @default.
- Q92240934 description "im März 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92240934 description "scientific article published on 06 March 2019" @default.
- Q92240934 description "wetenschappelijk artikel" @default.
- Q92240934 description "наукова стаття, опублікована 6 березня 2019" @default.
- Q92240934 name "Formulation and performance of Irbesartan nanocrystalline suspension and granulated or bead-layered dried powders - Part I" @default.
- Q92240934 name "Formulation and performance of Irbesartan nanocrystalline suspension and granulated or bead-layered dried powders - Part I" @default.
- Q92240934 type Item @default.
- Q92240934 label "Formulation and performance of Irbesartan nanocrystalline suspension and granulated or bead-layered dried powders - Part I" @default.
- Q92240934 label "Formulation and performance of Irbesartan nanocrystalline suspension and granulated or bead-layered dried powders - Part I" @default.
- Q92240934 prefLabel "Formulation and performance of Irbesartan nanocrystalline suspension and granulated or bead-layered dried powders - Part I" @default.
- Q92240934 prefLabel "Formulation and performance of Irbesartan nanocrystalline suspension and granulated or bead-layered dried powders - Part I" @default.
- Q92240934 P1433 Q92240934-9B30907C-3628-4D4F-A515-E3B26EB8E8AD @default.
- Q92240934 P1476 Q92240934-7186430F-D582-4576-AD32-4481C724D2D6 @default.
- Q92240934 P2093 Q92240934-3BA140C4-DD59-4101-96E2-111B0E8FB805 @default.
- Q92240934 P2093 Q92240934-4A58D725-D05A-47D9-9B71-6E4E61348587 @default.
- Q92240934 P2093 Q92240934-8B91B345-415E-48D4-A68B-1811A5A83491 @default.
- Q92240934 P2093 Q92240934-CDD32597-70D7-40C9-A2E5-E900B1D13D9A @default.
- Q92240934 P2093 Q92240934-E2EDD9E2-1151-4098-B8A7-967F7A31C55F @default.
- Q92240934 P2093 Q92240934-E3B679AA-CAB8-403C-90FA-F75746F61365 @default.
- Q92240934 P304 Q92240934-1C34DA48-D51C-496E-8523-CEDFE2DBFBA6 @default.
- Q92240934 P31 Q92240934-D62CC0FE-AAC0-4D8A-AABF-D4A89CC13C33 @default.
- Q92240934 P356 Q92240934-62FD581A-BFA3-4D74-8292-FD3E42BD689F @default.
- Q92240934 P478 Q92240934-93452601-CC9D-4517-89DC-7928C250C6C3 @default.
- Q92240934 P50 Q92240934-5D01E32C-3738-442F-9188-72BE1BB4E531 @default.
- Q92240934 P577 Q92240934-7F46A61E-078F-4E70-95AE-D652E0717170 @default.
- Q92240934 P698 Q92240934-2221D8AB-40FE-4B63-8425-CA5844F83D48 @default.
- Q92240934 P356 J.IJPHARM.2019.03.007 @default.
- Q92240934 P698 30851385 @default.
- Q92240934 P1433 Q6051539 @default.
- Q92240934 P1476 "Formulation and performance of Irbesartan nanocrystalline suspension and granulated or bead-layered dried powders - Part I" @default.
- Q92240934 P2093 "Indrajit Ghosh" @default.
- Q92240934 P2093 "Saikishore Meruva" @default.
- Q92240934 P2093 "Shawreen Shah" @default.
- Q92240934 P2093 "Shyam Karki" @default.
- Q92240934 P2093 "Sumit Kumar" @default.
- Q92240934 P2093 "William Bowen" @default.
- Q92240934 P304 "118189" @default.
- Q92240934 P31 Q13442814 @default.
- Q92240934 P356 "10.1016/J.IJPHARM.2019.03.007" @default.
- Q92240934 P478 "568" @default.
- Q92240934 P50 Q89674539 @default.
- Q92240934 P577 "2019-03-06T00:00:00Z" @default.
- Q92240934 P698 "30851385" @default.